Literature DB >> 9389360

Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma.

G Pinotti1, E Zucca, E Roggero, A Pascarella, F Bertoni, A Savio, E Savio, C Capella, E Pedrinis, P Saletti, E Morandi, G Santandrea, F Cavalli.   

Abstract

The purpose of this paper is to report the clinical characteristics and treatment outcome following different therapeutic approaches in a large series of patients with primary low-grade MALT lymphoma of the stomach. A total of ninety-three patients (median age 63 years) were reviewed. The patients were treated by different modalities (local treatment alone, combined treatment, chemotherapy, antibiotics alone); seven patients refused any treatment. The antibiotic-treated group of patients was prospectively followed with regular endoscopic biopsies, and their responses were histologically evaluated. The 5-years projected overall survival is 82% (95% C.I.; 67%-91%) in the series as a whole. Second tumors were observed in 21.5% of the patients in this series (95% CI 14%v to 31%). There was no apparent difference in overall survival and event-free survival between patients who received different treatments. In the antibiotic-treated group histologic regression of MALT lymphoma was documented in 67% of patients (95% CI 51% to 80%). In conclusion the indolent nature of the disease justifies a conservative approach. The use of antibiotics as first-line therapy may avert or at least postpone the indication for surgical resection in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389360     DOI: 10.3109/10428199709050889

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  32 in total

Review 1.  Management of non-Hodgkin's lymphomas.

Authors:  P J Mounter; A L Lennard
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

Review 2.  Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: A review of the literature.

Authors:  Erhan Hamaloglu; Serdar Topaloglu; Arif Ozdemir; Ahmet Ozenc
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Treatment outcome of gastric extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in the Hong Kong Chinese population: a single centre experience.

Authors:  Ka-Shing Cheng; Yiu-Kay Chan; Yat-Wah Yeung
Journal:  J Gastrointest Oncol       Date:  2013-06

4.  MALT lymphoma of the rectum, presenting with rectal prolapsus: a case report.

Authors:  Feyzullah Ersoz; Ahmet Burak Toros; Hasan Bektas; Ozhan Ozcan; Oguz Koc; Soykan Arikan
Journal:  Cases J       Date:  2010-01-21

5.  Low Grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma: Clinicopathological Factors Associated with Helicobacter pylori Eradication and Tumor Regression.

Authors:  Yoon Jin Choi; Dong Ho Lee; Ji Yeon Kim; Ji Eun Kwon; Jae Yeon Kim; Hyun Jin Jo; Cheol Min Shin; Hyun Young Kim; Young Soo Park; Nayoung Kim; Hyun Chae Jung; In Sung Song
Journal:  Clin Endosc       Date:  2011-12-31

6.  Pulmonary MALT Lymphoma in Patients with Sjögren's Syndrome.

Authors:  Ralph Yachoui; Chady Leon; Kajal Sitwala; Mazen Kreidy
Journal:  Clin Med Res       Date:  2017-05-09

7.  Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.

Authors:  Ikue Okamura; Hisao Imai; Keita Mori; Kazuto Ogura; Atsushi Isoda; Keichiro Mihara; Morio Matsumoto; Ryusei Saito; Toshiaki Takahashi; Takashi Ikeda
Journal:  Int J Hematol       Date:  2014-11-07       Impact factor: 2.490

Review 8.  Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Jeong Bae Park; Ja Seol Koo
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 9.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

10.  Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial.

Authors:  Barry W Hancock; Wendi Qian; David Linch; Jean-Charles Delchier; Paul Smith; Ira Jakupovic; Cathy Burton; Robert Souhami; Andrew Wotherspoon; Christiane Copie-Bergman; Carlo Capella; Catherine Traulle; Michael Levy; Sergio Cortelazzo; Andres J M Ferreri; Achille Ambrosetti; Graziella Pinotti; Giovanni Martinelli; Umberto Vitolo; Franco Cavalli; Christian Gisselbrecht; Emanuele Zucca
Journal:  Br J Haematol       Date:  2008-11-22       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.